Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Rheumatoid Arthritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04834050
What this trial is testing

Can 4 Weeks of Exercise Program Change Quadriceps Architecture in Patients With Rheumatoid Arthritis

Who this might be right for
Arthritis, RheumatoidKnee OsteoarthritisQuadriceps Muscle Atrophy+2 more
Ovgu Bickici 37
Not applicableStudy completedNCT01283399
What this trial is testing

An Observational Study of Rituximab in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 79
Not applicableNot Yet RecruitingNCT07374367
What this trial is testing

Isthmin-1 as a Biomarker of Disease Activity in Rheumatoid Arthritis: Correlation With Musculoskeletal Ultrasound Findings

Who this might be right for
Disease Activity
Amera Imam Abdel - Ghany Ahmed 66
Testing effectiveness (Phase 2)Ended earlyNCT01296711
What this trial is testing

Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056

Who this might be right for
Rheumatoid Arthritis
UCB BIOSCIENCES, Inc. 190
Post-approval studies (Phase 4)WithdrawnNCT01067430
What this trial is testing

Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Northumbria Healthcare NHS Foundation Trust
Testing effectiveness (Phase 2)Ended earlyNCT00634933
What this trial is testing

Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Pfizer 222
Testing effectiveness (Phase 2)Study completedNCT04049448
What this trial is testing

Study Evaluating the Long-Term Safety and Efficacy of ABX464 in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Abivax S.A. 40
Not applicableStudy completedNCT01388608
What this trial is testing

Standard Disease Activity Parameters and Step Activity in Patients With Rheumatoid Arthritis Receiving Etanercept

Who this might be right for
Rheumatoid Arthritis
University Hospital Muenster 28
Testing effectiveness (Phase 2)WithdrawnNCT01204138
What this trial is testing

Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA

Who this might be right for
Arthritis, Rheumatoid
Stanford University
Large-scale testing (Phase 3)Study completedNCT00048568
What this trial is testing

A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 1,250
Large-scale testing (Phase 3)Study completedNCT00535782
What this trial is testing

The Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 132
Large-scale testing (Phase 3)Study completedNCT00146367
What this trial is testing

Evaluation of the Active Living Every Day Exercise Program for People With Arthritis

Who this might be right for
Arthritis
Centers for Disease Control and Prevention 355
Not applicableUnknownNCT06540573
What this trial is testing

The Relationship Between Serum Chemokine Ligand 21 (CCL-21) Level and Disease Activity

Who this might be right for
Rheumatoid ArthritisOsteoarthritis
Gaziosmanpasa Research and Education Hospital 60
Post-approval studies (Phase 4)Ended earlyNCT02659150
What this trial is testing

Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Massachusetts General Hospital 16
Testing effectiveness (Phase 2)Study completedNCT03926195
What this trial is testing

Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisAnkylosing Spondylitis+1 more
Lakefront Biotherapeutics NV 109
Large-scale testing (Phase 3)Study completedNCT01689532
What this trial is testing

CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine

Who this might be right for
Arthritis, Rheumatoid
Janssen Pharmaceutical K.K. 122
Testing effectiveness (Phase 2)Study completedNCT00345748
What this trial is testing

Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 194
Testing effectiveness (Phase 2)Study completedNCT03368235
What this trial is testing

Early Phase Study to Assess Efficacy and Safety of AZD9567 Versus Prednisolone in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AstraZeneca 21
Large-scale testing (Phase 3)Study completedNCT01604343
What this trial is testing

CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D)

Who this might be right for
Arthritis, Rheumatoid
Janssen Research & Development, LLC 1,670
Post-approval studies (Phase 4)Study completedNCT04485325
What this trial is testing

Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients

Who this might be right for
Rheumatic Arthritis
Dr. Frank Behrens 92
Next Page